Hypertension and Antiangiogenesis: The Janus Face of VEGF Inhibitors

JACC CardioOncol. 2019 Sep 24;1(1):37-40. doi: 10.1016/j.jaccao.2019.08.010. eCollection 2019 Sep.
No abstract available

Keywords: VEGF inhibitors; antihypertensive drugs; blood pressure; cancer; renin angiotensin aldosterone; tyrosine kinase inhibitors.

Publication types

  • Editorial
  • Comment